Stock Events

Stock Events

MDxHealth SA 

€3.02
51
-€0.12-3.76% Friday 16:35

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.19
-0.16
-0.13
-0.09
Expected EPS
-0.09238
Actual EPS
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health operates in the liquid biopsy and cancer diagnostics market, directly competing with MDxHealth's focus on cancer detection and monitoring.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics offers comprehensive genetic testing, directly competing with MDxHealth in the genomic diagnostics space.
Myriad Genetics
MYGN
Mkt Cap302.25M
Myriad Genetics specializes in molecular diagnostic tests, including for cancer, competing with MDxHealth's diagnostic tests.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing systems that compete with MDxHealth's technologies for genetic analysis in diagnostics.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides sequencing and array-based solutions for genetic analysis, competing with MDxHealth in the genomic diagnostics market.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen offers sample to insight solutions including for cancer, competing with MDxHealth in the field of molecular diagnostics.

About

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Show more...
CEO
Mr. Michael K. McGarrity
Employees
177
Country
Belgium
ISIN
BE0974461940
WKN
000A0J3N3

Listings

MU
DE
O6C0.MU
STU
DE
O6C0.STU
LSE
GB
0O8G.LSE
STU
DE
O6C1.STU

0 Comments

Share your thoughts

FAQ

What is MDxHealth SA stock price today?▼
The current price of MDXH.BR is €3.02 EUR — it has decreased by -3.76% in the past 24 hours. Watch MDxHealth SA stock price performance more closely on the chart.
What is MDxHealth SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Euronext Brussels exchange MDxHealth SA stocks are traded under the ticker MDXH.BR.
What were MDxHealth SA earnings last quarter?▼
MDXH.BR earnings for the last quarter are 0 EUR per share, whereas the estimation was -0.24 EUR resulting in a +100% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does MDxHealth SA have?▼
As of September 04, 2026, the company has 177 employees.
In which sector is MDxHealth SA located?▼
MDxHealth SA operates in the Health & Wellness sector.
When did MDxHealth SA complete a stock split?▼
MDxHealth SA has not had any recent stock splits.
Where is MDxHealth SA headquartered?▼
MDxHealth SA is headquartered in Herstal, Belgium.